Aumolertinib Promising Maintenance Therapy in EGFR+ NSCLC ...Middle East

Medscape - News
Aumolertinib maintenance therapy led to a significant improvement in progression-free survival in unresectable, stage III, EGFR-mutated non–small cell lung cancer. Medscape Medical News

Hence then, the article about aumolertinib promising maintenance therapy in egfr nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aumolertinib Promising Maintenance Therapy in EGFR+ NSCLC )

Apple Storegoogle play

Last updated :

Also on site :



Latest News